“ Lantheus the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes”
Lantheus could be very very interested, & keen - to secure Clarity.
Very long established radiopharmaceutical company, long history in development and to where the company is positioned today. (since about 1956. )
Similar market cap to Telix , & Telix is now beating them in the radiopharmaceuticals diagnostic space - Nasdaq Lantheus could likely want to best compete and position for into the future.
https://www.prnewswire.com/news-releases/lantheus-to-acquire-evergreen-theragnostics-for-upfront-payment-of-250-million-to-drive-strategic-evolution-into-fully-integrated-radiopharmaceutical-leader-302361401.html
- Forums
- ASX - By Stock
- Ann: SECuRE trial update
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
1.88%
!
$2.09

“ Lantheus the leading radiopharmaceutical-focused company...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.09 |
Change
-0.040(1.88%) |
Mkt cap ! $671.8M |
Open | High | Low | Value | Volume |
$2.15 | $2.21 | $2.09 | $3.560M | 1.666M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 37360 | $2.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.10 | 10220 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 37360 | 2.090 |
3 | 17562 | 2.080 |
2 | 11254 | 2.070 |
4 | 18476 | 2.060 |
3 | 948 | 2.050 |
Price($) | Vol. | No. |
---|---|---|
2.100 | 10220 | 1 |
2.110 | 12628 | 2 |
2.120 | 97 | 1 |
2.130 | 10222 | 1 |
2.140 | 10222 | 1 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online